Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Ipilimumab
Related studies linked through entity extraction aliases.
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ipilimumab + Temozolomide in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Immunotherapy to Treat Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine
- Status
- COMPLETED
- Phase
- PHASE1
Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Compassionate Use Trial for Unresectable Melanoma With Ipilimumab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2